An antiviral mechanism of nitric oxide: Inhibition of a viral protease

Immunity

Volumn 10, Issue 1, 1999, Pages 21-28

  Saura, Marta ^a   Zaragoza, Carlos ^a   McMillan, Audrey ^a   Quick, Richard A ^a   Hohenadl, Christine ^b   Lowenstein, John M ^c   Lowenstein, Charles J ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b INSTITUTE OF EPIDEMIOLOGY   (Germany)

^c BRANDEIS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NITRIC OXIDE;

ARTICLE; COXSACKIE VIRUS; ENZYME INACTIVATION; HOST RESISTANCE; HUMAN; HUMAN CELL; PRIORITY JOURNAL; VIRUS INFECTION; VIRUS REPLICATION; VIRUS VIRULENCE;

EID: 0033026199     PISSN: 10747613     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1074-7613(00)80003-5     Document Type: Article

References (70)

1. Akaike, T., Noguchi, Y., Ijiri, S., Setoguchi, K., Suga, M., Zheng, Y.M., Dietzschold, B., and Maeda, H. (1996). Pathogenesis of influenza virus-induced pneumonia: Involvement of both nitric oxide and oxygen radicals. Proc. Natl. Acad. Sci. USA 93, 2448-2453.
2. Akarid, K., Sinet, M., Desforges, B., and Gougerot-Pocidalo, M.A. (1995). Inhibitory effect of nitric oxide on the replication of a murine retrovirus in vitro and in vivo. J. Virol. 69, 7001-7005.
3. Aldape, K., Huizinga, H., Bouvier, J., and McKerrow, J. (1994). Naegleria fowleri: Characterization of a secreted histolytic cysteine protease. Exper. Parasitol. 78, 230-241.
4. Babe, L.M., and Craik, C.S. (1997). Viral proteases: Evolution of diverse structural motifs to optimize function. Cell 91, 427-430.
5. Bailly, E., Jambou, R., Savel, J., and Jaureguiberry, G. (1992). Plasmodium falciparum: Differential sensitivity in vitro to E-64 (cysteine protease inhibitor) and Pepstatin A (aspartyl protease inhibitor). J. Protozool. 39, 593-599.
6. Bedi, G.S., and Williams, T. (1994). Purification and characterization of a collagen-degrading protease from Porphyromonas gingivalis. J. Biol. Chem. 269, 599-606.
7. Bi, Z., and Reiss, C.S. (1995). Inhibition of vesicular stomatitis virus infection by nitric oxide. J. Virol. 69, 2208-2213.
8. Bukrinsky, M.I., Nottet, H.S., Schmidtmayerova, H., Dubrovsky, L., Flanagan, C.R., Mullins, M.E., Lipton, S.A., and Gendelman, H.E. (1995). Regulation of nitric oxide synthase activity in human immuno-deficiency virus type 1 (HIV-1)-infected monocytes: Implications for HIV-associated neurological disease. J. Exper. Med. 181, 735-745.
9. Croen, K.D. (1993). Evidence for antiviral effect of nitric oxide. Inhibition of herpes simplex virus type 1 replication. J. Clin. Invest. 91, 2446-2452.
10. Dominguez, J.N., Lopez, S., Charris, J., Iarruso, L., Lobo, G., Semenov, A., Olson, J.E., and Rosenthal, P.J. (1997). Synthesis and antimalarial effects of phenothiazine inhibitors of a Plasmodium falciparum cysteine protease. J. Med. Chem. 40, 2726-2732.
11. Dougherty, W.G., and Semler, B.L. (1993). Expression of virus encoded proteinases: Functional and structural similarities with cellular enzymes. Microbiol. Rev. 57, 781-822.
12. Eakin, A.E., Mills, A.A., Harth, G., McKerrow, J.H., and Craik, C.S. (1992). The sequence, organization, and expression of the major cysteine protease (cruzain) from Trypanosoma cruzi. J. Biol. Chem. 267, 7411-7420.
13. Ellman, G.L. (1959). Arch. Biochem. Biophys. 82, 70-77.
14. Fang, F.C. (1997). Mechanisms of nitric oxide related antimicrobial activity. J. Clin. Invest. 99, 2818-2825.
15. Flynn, D.L., Becker, D.P., Dilworth, V.M., Highkin, M.K., Hippenmeyer, P.J., Houseman, K.A., Levine, L.M., Li, M., Moormann, A.E., Rankin, A., et al. (1997). The herpesvirus protease: Mechanistic studies and discovery of inhibitors of the human cytomegalovirus protease. Drug. Des. Discov. 15, 3-15.
16. Gauntt, C.J., Trousdale, M.D., Labadie, D.R., Paque, R.E., and Nealon, T. (1979). Properties of coxsackievirus B3 variants which are amyocarditic or myocarditic for mice. J. Med. Virol. 3, 207-220.
17. Ghosh, S., and Lowenstein, J.M. (1996). A multifunctional vector system for heterologous expression of proteins in E.coli. Gene 176, 249-255.
18. Gluzman, I.Y., Francis, S.E., Oksman, A., Smith, C.E., Duffin, K.L., and Goldberg, D.E. (1994). Order and specificity of the Plasmodium falciparum hemoglobin degradation pathway. J. Clin. Invest. 93, 1602-1608.
19. Gorbalenya, A.E., and Svitkin, Y.V. (1983). Protease of encephalomyocarditis virus: Purification and role of SH groups in processing of the structural proteins precursor. Biochemistry (USSR) 48, 385-395.
20. Gubba, S., Low, D.E., and Mussen, J.M. (1998). Expression and characterization of group A streptococcus extracellular cysteine protease recombinant mutant proteins and documentation of seroconversion during human invasive disease episodes. Infect. Immun. 66, 765-770.
21. Haddad, I.Y., Sorscher, E.J., Garver, R.I., Jr., Hong, J., Tzeng, E., And Matalon, S. (1997). Modulation of adenovirus-mediated gene transfer by nitric oxide. Am. J. Respir. Cell Mol. Biol. 16, 501-509.
22. Hammerle, T., Hellen, C.U., and Wimmer, E. (1991). Site-directed mutagenesis of the putative catalytic triad of poliovirus 3C proteinase. J. Biol. Chem. 266, 5412-5416.
23. Harth, G., Andrews, N., Mills, A.A., Engel, J.C., Smith, R., and McKerrow, J.H. (1993). Peptide-fluoromethyl ketones arrest intracellular replication and intercellular transmission of trypanosoma cruzi. Mol. Biochem. Parasitol. 58, 17-24.
24. Hellen, C.U., Kräusslich, H.G., and Wimmer, E. (1989). Proteolytic processing of polyproteins in the replication of RNA viruses. BioChemistry 28, 9881-9890.
25. Holzman, T.F., and Baldwin, T.O. (1980). Proteolytic inactivation of luciferases from three species of luminous marine bacteria, Beneckea harveyi, photobacterium fischeri, and photobacterium phosphoreum: Evidence of a conserved structural feature. Proc. Natl. Acad. Sci. USA 77, 6363-6367.
26. Hooper, D.C., Ohnishi, S.T., Kean, R., Numagami, Y., Dietzschold, B., and Koprowski, H. (1995). Local nitric oxide production in viral and autoimmune diseases of the central nervous system. Proc. Natl. Acad. Sci. USA 92, 5312-5316.
27. Ivanoff, L.A., Towatari, T., Ray, J., Korant, B.D., and Petteway, S.R., Jr. (1986). Expression and site-specific mutagenesis of the poliovirus 3C protease in Escherichia coli. Proc. Natl. Acad. Sci. USA 83, 5392-5396.
28. Kapur, V., Majesky, M.W., Li, L.L., Black, R.A., and Musser, J.M. (1993a). Cleavage of interleukin 1 beta (IL-1 beta) precursor to produce active IL-1 beta by a conserved extracellular cysteine protease from streptococcus pyogenes. Proc. Natl. Acad. Sci. USA 90, 7676-7680.
29. Kapur, V., Topouzis, S., Majesky, M.W., Li, L.L., Hamrick, M.R., Hamill, R.J., Patti, J.M., and Musser, J.M. (1993b). A conserved Streptococcus pyogenes extracellular cysteine protease cleaves human fibronectin and degrades vitronectin. Microb. Pathog. 15, 327-346.
30. Karupiah, G., Xie, Q.W., Buller, R.M., Nathan, C., Duarte, C., and MacMicking, J.D. (1993). Inhibition of viral replication by interferon-gamma-induced-induced nitric oxide synthase. Science 261, 1445-1448.
31. Kim, Y.M., Talanian, R.V., and Billiar, T.R. (1997). Nitric oxide inhibits apoptosis by preventing increases in caspase-3-like activity via two distinct mechanisms. J. Biol. Chem. 272, 31138-31148.
32. Klump, W.M., Bergmann, I., Muller, B.C., Ameis, D., and Kandolf, R. (1990). Complete nucleotide sequence of infectious Coxsackievirus B3 cDNA: Two initial 5′ uridine residues are regained during plusstrand RNA synthesis. J. Virol. 64, 1573-1583.
33. Komatsu, T., Bi, Z., and Reiss, C.S. (1996). Interferon-gamma induced type I nitric oxide synthase activity inhibits viral replication in neurons. J. Neuroimmunol. 68, 101-108.
34. Kreil, T.R., and Eibl, M.M. (1996). Nitric oxide and viral infection: NO antiviral activity against a flavivirus in vitro, and evidence for contribution to pathogenesis in experimental infection in vivo. VirolOgy 219, 304-306.
35. Kräusslich, H.G., and Wimmer, E. (1988). Viral proteinases. Annu. Rev. Biochem. 57, 701-754.
36. Kumar, S., Van Pelt, J.F., O'Dowd, C.A., Hollingdale, M.R., and Sinden, R.E. (1994). Effects of hormones and cysteine protease modulators on infection of HepG2 cells by Plasmodium berghei sporozoites in vitro determined by ELISA immunoassay. J. Parasitol. 80, 414-420.
37. Kuramitsu, H., Tokuda, M., Yoneda, M., Duncan, M., and Cho, M.I. (1997). Multiple colonization defects in a cysteine protease mutant of Porphyromonas gingivalis. J. Period. Res. 32, 140-142.
38. Lawson, M.A., and Semler, B.L. (1990). Picornavirus protein processing - Enzymes, substrates, and genetic regulation. Curr. Top. Microbiol. Immunol. 161, 49-80.
39. Li, Z., Chen, X.D.E.Z., Mendis, C., Ring, C.S., Roush, W.R., Fegley, G., Li, R., and Rosenthal, P.J. (1994). Anti-malarial drug development using models of enzyme structure. Chem. Biol. 1, 31-37.
40. Li, J., Billiar, T.R., Talanian, R.V., and Kim, Y.M. (1997). Nitric oxide reversibly inhibits seven members of the caspase family via S-nitrosylation. Biochem. Biophys. Res. Commun. 240, 419-424.
41. Liu, R.H., Jacob, J.R., Tennant, B.C., and Hotchkiss, J.H. (1992). Nitrite and nitrosamine synthesis by hepatocytes isolated from normal woodchucks (Marmota monax) and woodchucks chronically infected with woodchuck hepatitis virus. Cancer Res. 52, 4139-4143.
42. Lowenstein, C.J., Hill, S.L., Lafond-Walker, A., Wu, J., Allen, G., Landavere, M., Rose, N.R., and Herskowitz, A. (1996). Nitric oxide inhibits viral replication in murine myocarditis. J. Clin. Invest. 97, 1837-1843.
43. Lukomski, S., Sreevatsan, S., Amberg, C., Reichardt, W., Woischnik, M., Podbielski, A., and Musser, J.M. (1997). Inactivation of Streptococcus pyogenes extracellular cysteine protease significantly decreases mouse lethality of serotype M3 and M49 strains. J. Clin. Invest. 99, 2574-2580.
44. MacMicking, J.D., Xie, Q.W., and Nathan, C. (1997). Nitric oxide and macrophage function. In Annual Review Of Immunology, W.E. Paul, C.G. Fathman, and H. Metzger, eds. (Palo Alto, CA: Annual Reviews, Inc.), pp. 323-350.
45. Mannick, J.B. (1995). The antiviral role of nitric oxide. Res. Immunol. 146, 693-697.
46. Mannick, J.B., Asano, K., Izumi, K., Kieff, E., and Stamler, J.S. (1994). Nitric oxide produced by human B lymphocytes inhibits apoptosis and Epstein-Barr virus reactivation. Cell 79, 1137-1146.
47. Mannick, J.B., Miao, X.Q., and Stamler, J.S. (1997). Nitric oxide inhibits Fas-induced apoptosis. J. Biol. Chem. 272, 24125-24128.
48. McGrath, M.E., Eakin, A.E., Engel, J.C., McKerrow, J.H., Craik, C.S., and Fletterick, R.J. (1995). The crystal structure of cruzain: A therapeutic target for Chagas' disease. J. Mol. Biol. 247, 251-259.
49. Melkova, Z., and Esteban, M. (1995). Inhibition of vaccinia virus DNA replication by inducible expression of nitric oxide synthase. J. Immunol. 155, 5711-5718.
50. Mikami, S., Kawashima, S., Kanazawa, K., Hirata, K., Katayama, Y., Hotta, H., Hayashi, Y., Ito, H., and Yokoyama, M. (1996). Expression of nitric oxide synthase in a murine model of viral myocarditis induced by coxsackievirus B3. Biochem. Biophys. Res. Comm. 220, 983-989.
51. Miyashita, K., Kusumi, M., Utsumi, R., Katayama, S., Noda, M., Komano, T., and Satoh, N. (1993). Site-directed mutagenesis of the putative active site residues of 3C proteinase of coxsackievirus B3: Evidence of a functional relationship with trypsin-like serine proteinases. Protein. Eng. 6, 189-193.
52. Mohr, S., Zech, B., Lapetina, E.G., and Brune, B. (1997). Inhibition of caspase-3 by S-nitrosation and oxidation caused by nitric oxide. Biochem. Biophys. Res. Commun. 238, 387-391.
53. Musser, J.M., Stockbauer, K., Kapur, V., and Rudgers, G.W. (1996). Substitution of cysteine 192 in a highly conserved streptococcus pyogenes extracellular cysteine protease (interleukin 1beta convertase) alters proteolytic activity and ablates zymogen processing. Infect. Immun. 64, 1913-1917.
54. Orr, D.C., Long, A.C., Kay, J., Dunn, B.M., and Cameron, J.M. (1989). Hydrolysis of a series of synthetic peptide substrates by the human rhinovirus 14 3C proteinase, cloned and expressed in Escherichia coli. J. Gen. Virol. 70, 2931-2942.
55. Palmberg, A. (1990). Proteolytic processing of picornaviral polyprotein. Annu. Rev. Microbiol. 44, 603-623.
56. Reiss, C.S., and Komatsu, T. (1998). Does nitric oxide play a critical role in viral infections? J. Virol. 72, 4547-4551.
57. Rolph, M.S., Ramshaw, I.A., Rockett, K.A., Ruby, J., and Cowden, W.B. (1996). Nitric oxide production is increased during murine vaccinia virus infection, but may not be essential for virus clearance. Virology 217, 470-477.
58. Saville, B. (1958). A scheme for the colorimetric determination of microgram amounts of thiols. Analyst 83, 670-672.
59. Selzer, P.M., Chen, X., Chan, V.J., Cheng, M., Kenyon, G.L., Kuntz, I.D., Sakanari, J.A., Cohen, F.E., and McKerrow, J.H. (1997). Leishmania major: Molecular modeling of cysteine proteases and prediction of new nonpeptide inhibitors. Exp. Parasitol. 87, 212-221.
60. Stamler, J.S. (1994). Redox signaling: Nitrosylation and related target interactions of nitric oxide. Cell 78, 931-936.
61. Stamler, J.S., Simon, D.I., Osborne, J.A., Mullins, M.E., Jaraki, O., Michel, T., Singel, D.J., and Loscalzo, J. (1992a). S-nitrosylation of proteins with nitric oxide: Synthesis and characterization of biologically active compounds. Proc. Natl. Acad. Sci. USA 89, 444-448.
62. Stamler, J.S., Singel, D.J., and Loscalzo, J. (1992b). Biochemistry of nitric oxide and its redox-activated forms. Science 258, 1898-1902.
63. Stamler, J.S., Toone, E.J., Lipton, S.A., and Sucher, N.J. (1997). (S)NO signals: Translocation, regulation, and a consensus motif. Neuron 18, 691-696.
64. Thompson, J.F., Geoghegan, K.F., Lloyd, D.B., Lanzetti, A.J., Magyar, R.A., Anderson, S.M., and Branchini, B.R. (1997). Mutation of a protease-sensitive region in firefly luciferase alters light emission properties. J. Biol. Chem. 272, 18766-18771.
65. Tucker, P.C., Griffin, D.E., Choi, S., Bui, N., and Wesselingh, S. (1996). Inhibition of nitric oxide synthesis increases mortality in Sindbis virus encephalitis. J. Virol. 70, 3972-3977.
66. Van Dam, A.M., Bauer, J., Man-A-Hing, W.K., Marquette, C., Tilders, F.J., and Berkenbosch, F. (1995). Appearance of inducible nitric oxide synthase in the rat central nervous system after rabies virus infection and during experimental allergic encephalomyelitis but not after peripheral administration of endotoxin. J. Neurosci. Res. 40, 251-260.
67. Wasilewski, M.M., Lim, K.C., Phillips, J., and McKerrow, J.H. (1996). Cysteine protease inhibitors block schistosome hemoglobin degradation in vitro and decrease worm burden and egg production in vivo. Mol. Biochem. Parasitol. 81, 179-189.
68. Zaragoza, C., Ocampo, C.J., Saura, M., McMillan, A., and LoWenstein, C.J. (1997). Nitric oxide inhibition of coxsackievirus replication in vitro. J. Clin. Invest. 100, 1760-1767.
69. Zaragoza, C., Saura, M., Liew, F.Y., Moncada, S., and Lowenstein, C.J. (1998). The role of NOS2 in coxsackievirus myocarditis. Proc. Natl. Acad. Sci. USA 95, 2469-2474.
70. Zhang, Y., Xu, A., Nomen, M., Walsh, M., Keaney, J.F., and Loscalzo, J. (1996). Nitrosation of tryptophan residue(s) in serumalbumion and model dipeptides. J. Biol. Chem. 271, 14271-14279.